NewAmsterdam Pharma
NAMS
NAMS
181 hedge funds and large institutions have $4.16B invested in NewAmsterdam Pharma in 2025 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
2.51% less ownership
Funds ownership: 107.06% → 104.55% (-2.5%)
30% less call options, than puts
Call options by funds: $11.1M | Put options by funds: $15.9M
Holders
181
Holding in Top 10
7
Calls
$11.1M
Puts
$15.9M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$39.5M | |
| 3 | +$36.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.9M |
| 5 |
Goldman Sachs
New York
|
+$30.8M |
Top Sellers
| 1 | -$124M | |
| 2 | -$82.7M | |
| 3 | -$42.8M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$42.6M |
| 5 |
Morgan Stanley
New York
|
-$35.1M |
